<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: <z:chebi fb="56" ids="16716">Benzene</z:chebi> has been consistently associated with <z:e sem="disease" ids="C0947743,C0018939" disease_type="Disease or Syndrome" abbrv="">hematological disorders</z:e>, including <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> and <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>, but the mechanisms causing these disorders are still unclear </plain></SENT>
<SENT sid="1" pm="."><plain>Various metabolites of <z:chebi fb="56" ids="16716">benzene</z:chebi> lead to toxicity through the production of reactive oxygen species (ROS), the inhibition of topoisomerase and DNA damage </plain></SENT>
<SENT sid="2" pm="."><plain>However, <z:chebi fb="56" ids="16716">benzene</z:chebi> itself is considered to have no mutagenic or cytotoxic activity </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, we investigated the effects of <z:chebi fb="56" ids="16716">benzene</z:chebi> itself on a human myeloid cell line with or without <z:chebi fb="56" ids="16716">benzene</z:chebi> metabolizing <z:chebi fb="0" ids="23924">enzyme inhibitors</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: A human myeloid cell line, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60, was exposed to <z:chebi fb="56" ids="16716">benzene</z:chebi> with or without <z:chebi fb="0" ids="38559">cytochrome P450</z:chebi> 2E1 or myeloperoxidase inhibitor </plain></SENT>
<SENT sid="5" pm="."><plain>Cytotoxicity was evaluated in terms of global DNA methylation levels, induction of <z:mpath ids='MPATH_3'>apoptosis</z:mpath>, and ROS production </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: <z:chebi fb="56" ids="16716">Benzene</z:chebi> did not change global DNA methylation levels </plain></SENT>
<SENT sid="7" pm="."><plain>However, <z:chebi fb="56" ids="16716">benzene</z:chebi> itself increased the levels of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and ROS </plain></SENT>
<SENT sid="8" pm="."><plain>This cytotoxicity did not change with the addition of <z:chebi fb="56" ids="16716">benzene</z:chebi> metabolizing <z:chebi fb="0" ids="23924">enzyme inhibitors</z:chebi> </plain></SENT>
<SENT sid="9" pm="."><plain><z:chebi fb="56" ids="16716">Benzene</z:chebi> itself increased the <z:chebi fb="2" ids="33699">mRNA</z:chebi> levels of <z:mp ids='MP_0003674'>oxidative stress</z:mp>-related genes and transcription factors of activator protein-1 </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:chebi fb="56" ids="16716">Benzene</z:chebi> did not influence global DNA methylation in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 cells, but had cytotoxic effects and changed gene expression levels </plain></SENT>
<SENT sid="11" pm="."><plain>To elucidate the mechanisms of <z:chebi fb="56" ids="16716">benzene</z:chebi> toxicity, <z:chebi fb="56" ids="16716">benzene</z:chebi> itself as well as <z:chebi fb="56" ids="16716">benzene</z:chebi> metabolites must be investigated </plain></SENT>
</text></document>